Thought Leadership

Latest Report


Vantage 2019 Preview

2019 expected to be volatile year for pharma and biotech industries The Vantage 2019 Preview looks at the risks and opportunities for the year ahead. Report Highlights Venture capital and IPO markets are expected to retrench The US FDA is expected to remain business friendly, but political gridlock may hinder pricing legislation Alexion’s…

Report library